You have no items in your shopping cart.
Search results for: 'IL-2'
- PD-L1 Antibody / B7-H1 / CD274 [orb606675]
ELISA, FACS, IF, IHC-P, WB
Human
Mouse
Monoclonal
Unconjugated
20 μg, 100 μg - ZEB1/NIL2A Rabbit Polyclonal Antibody [orb6954]Featured

FC, IF, IHC-Fr, IHC-P, WB
Human, Mouse, Rat
Bovine, Canine, Gallus, Porcine, Rabbit
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μl - Anti-IL-2R alpha (CD25) [Basiliximab] [orb348865]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg - Anti-IL-2R alpha (CD25) [Basiliximab] [orb348908]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg - Anti-IL-2R alpha (CD25) [Basiliximab] [orb1152522]
Blocking, FC, IF, IHC, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg



















![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348865_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb348908_6.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_1.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_2.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_3.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_4.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_5.png)
![Anti-IL-2R alpha (CD25) [Basiliximab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152522_6.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348866_1.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348866_2.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348866_3.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348866_4.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348866_5.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348909_1.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348909_2.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348909_3.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348909_4.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb348909_5.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_1.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_2.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_3.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_4.png)
![Anti-IL-2R [Daclizumab]](/images/pub/media/catalog/product/NewWebsite/35/orb1152523_5.png)



